Evidence map›Paper›PMID 37345802›Full record

ArticleJournal of the American Heart Association2023

Discrimination Between Pre- and Postcapillary Pulmonary Hypertension Using Platelet RNA.

Mohammad Arkani, Azar Kianzad, Samara Jansen, Josien Smit, Edward Post, Jip Ramaker, Tonny Lagerweij, Sjors G J G In't Veld, David P Noske, Anton Vonk Noordegraaf and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Mohammad ArkaniAmsterdam Cardiovascular Sciences Pulmonary Hypertension and Thrombosis Amsterdam The Netherlands.
Azar KianzadAmsterdam Cardiovascular Sciences Pulmonary Hypertension and Thrombosis Amsterdam The Netherlands.ORCID 0000-0003-1238-4139
Samara JansenAmsterdam Cardiovascular Sciences Pulmonary Hypertension and Thrombosis Amsterdam The Netherlands.ORCID 0000-0003-3493-3573
Josien SmitAmsterdam Cardiovascular Sciences Pulmonary Hypertension and Thrombosis Amsterdam The Netherlands.ORCID 0000-0001-9828-0407
Edward PostDepartment of Neurosurgery Amsterdam UMC Location Vrije Universiteit Amsterdam Amsterdam The Netherlands.
Jip RamakerDepartment of Neurosurgery Amsterdam UMC Location Vrije Universiteit Amsterdam Amsterdam The Netherlands.
Tonny LagerweijDepartment of Neurosurgery Amsterdam UMC Location Vrije Universiteit Amsterdam Amsterdam The Netherlands.ORCID 0000-0003-1043-7452
Sjors G J G In't VeldDepartment of Neurosurgery Amsterdam UMC Location Vrije Universiteit Amsterdam Amsterdam The Netherlands.ORCID 0000-0002-3680-8437
David P NoskeDepartment of Neurosurgery Amsterdam UMC Location Vrije Universiteit Amsterdam Amsterdam The Netherlands.ORCID 0000-0001-5992-4468
Anton Vonk NoordegraafAmsterdam Cardiovascular Sciences Pulmonary Hypertension and Thrombosis Amsterdam The Netherlands.ORCID 0000-0002-4057-758X
Thomas WurdingerDepartment of Neurosurgery Amsterdam UMC Location Vrije Universiteit Amsterdam Amsterdam The Netherlands.
Myron G BestDepartment of Neurosurgery Amsterdam UMC Location Vrije Universiteit Amsterdam Amsterdam The Netherlands.
Harm-Jan BogaardAmsterdam Cardiovascular Sciences Pulmonary Hypertension and Thrombosis Amsterdam The Netherlands.ORCID 0000-0001-5371-0346
Amsterdam Neuroscience · NLLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Appropriate treatment of pulmonary hypertension (PH) is critically dependent on accurate discrimination between pre- and postcapillary PH. However, clinical discrimination is challenging and frequently requires a right heart catheterization. Existing risk scores to detect postcapillary PH have suboptimal discriminatory strength. We have previously shown that platelet-derived RNA profiles may have diagnostic value for PH detection. Here, we hypothesize that platelet-derived RNAs can be employed to select unique biomarker panels for the discrimination between pre- and postcapillary PH. Methods and Results Blood platelet RNA from whole blood was isolated and sequenced from 50 patients with precapillary PH (with different PH subtypes) as well as 50 patients with postcapillary PH. RNA panels were calculated by ANOVA statistics, and classifications were performed using a support vector machine algorithm, supported by particle swarm optimization. We identified in total 4279 different RNAs in blood platelets from patients with pre- and postcapillary PH. A particle swarm optimization-selected RNA panel of 1618 distinctive RNAs with differential levels together with a trained support vector machine algorithm accurately discriminated patients with precapillary PH from patients with postcapillary PH with 100% sensitivity, 60% specificity, 80% accuracy, and 0.95 (95% CI, 0.86-1.00) area under the curve in the independent validation series (n=20). Conclusions This proof-of-concept study demonstrates that particle swarm optimization/support vector machine-enhanced classification of platelet RNA panels may be able to discriminate precapillary PH from postcapillary PH. This research provides a foundation for the development of a blood test with a high negative predictive value that would improve early diagnosis of precapillary PH and prevents unnecessary invasive testing in patients with postcapillary PH.

Indexed as

Hypertension, PulmonaryBlood PlateletsCardiac CatheterizationHumansPredictive Value of TestsRisk Factorsblood plateletdiagnosismachine learningpulmonary hypertensionRNA

Identifiers

PMID37345802
PMCPMC10356096
OpenAlexW4381598215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.